The decreased cyclin D1 and c‐Myc expression in NU2058‐treated cells and tumor xenografts also proved that NU2058 suppressed CRC tumor growth by inhibiting the Wnt/β‐catenin pathway (Figure 2F,G). The gene discussed is MYC; the disease is colorectal carcinoma.